查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1830639

人工胰臟装置系统市场（按组件、适应症、设备类型、销售管道、最终用户和用户划分）—2025-2032 年全球预测

Artificial Pancreas Device System Market by Component, Indication, Device Type, Sales Channel, End User, User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，人工胰臟装置系统市场将成长至 6.8627 亿美元，复合年增长率为 8.66%。

主要市场统计数据
基准年2024年 3.5311亿美元
预计2025年 3.8164亿美元
预测年份：2032年 6.8627亿美元
复合年增长率（%） 8.66%

全面的介绍，展示监测、交付和演算法的融合将如何影响糖尿病护理的临床采用途径和相关人员的合作

本执行摘要首先重点介绍人工胰腺装置系统生态系统，概述其临床原理、技术组件以及推动其发展的监管和商业性力量之间的相互作用。该技术整合了持续血糖监测、胰岛素传输硬体和先进的控制演算法，可实现需要胰岛素的糖尿病患者的血糖管理自动化。临床结果、患者易用性、互通性标准和长期依从性仍然是临床效用和商业性应用的关键决定因素。

其中包括临床医生检验安全性和有效性，付款方定义报销途径，监管机构制定性能和网路安全标准，以及製造商优化成本、可製造性和服务模式。同时，现实世界证据和迭代软体更新越来越多地为迭代设备核准和上市后监测提供资讯。这种融合将影响短期临床应用和长期医疗服务模式的转变，其中与远端医疗、远端监控和数据驱动的患者管理的整合将成为价值创造和系统永续性的核心。

本介绍为详细分析技术曲折点、政策变化、市场进入动态和竞争定位奠定了基础。

技术融合和监管适应推动感测器精度、预测控制演算法和穿戴式外形规格的进步，重新定义糖尿病管理

在感测保真度、演算法智慧和人因工程学的推动下，人工胰臟装置系统格局正经历一场变革。感测器精度的提高和佩戴时间的延长降低了讯号杂讯和校准负担。因此，演算法设计正在从简单的比例方法转向基于模型的预测控制框架，该框架可以预测血糖值升高并即时调整给药方案。

同时，装置外形规格正在从笨重的手持式控制器演变为整合式穿戴装置和谨慎的贴片解决方案，这些方案优先考虑患者的舒适度和依从性。这种硬体小型化，加上改进的设备间通讯标准和云端分析功能，正在实现无缝远端监控和持续学习系统，从而改善临床决策支援。监管模式正在适应这种软体主导的创新，并制定了应对迭代演算法更新、真实世界证据要求和更严格的网路安全预期的途径。

这种转变不仅会改善临床结果，还会改变商业模式，激励製造商将设备与服务、数据分析和病人参与平台捆绑在一起，以增强长期保留和差异化奖励提案。

新的关税现实正在推动供应链重组和商业模式重新调整，推动在地化、双重采购和以服务为中心的定价策略

2025年新关税的实施，迫使人工胰臟设备价值链上的相关人员重新评估供应链的弹性和成本结构。由于感测器、微电子装置和胰岛素输送装置等组件通常来自多个地区，进口关税的变化将影响供应商资质、库存缓衝和近岸外包选项的决策。製造商已采取应对措施，加快关键次组件的本地化，并探索替代采购管道，以缓解利润率压缩。

为了应对关税主导的成本压力，定价策略已从固定产品定价转向包含服务的模式，透过订阅式远端监控和软体维护协议摊销设备成本。这种方法既能确保最终用户的收益，又能为供应商保留经常性收入。此外，製造商加强了与当地政策制定者和行业协会的合作，以明确关税分类，并争取对公共卫生必需的医疗设备和零件获得豁免。

在营运方面，企业优先考虑双重筹资策略和策略性库存布局，以最大程度地减少临床供应中断。临床试验申办方和医院采购团队也调整了订单顺序，以应对延长的前置作业时间，报销分析师也修改了成本效益评估，将调整后的采购成本纳入考虑。因此，关税动态引发了更广泛的重新评估，即如何在更具保护主义色彩的贸易环境中实现供应安全、合规性和永续定价。

多维、细分主导的观点底层技术、临床适应症、设备架构、销售管道、医疗保健环境和人口统计数据与策略重点连结起来

从细分市场分析中获得的见解揭示了组件选择、临床适应症、设备架构、销售管道、最终用户偏好和人口统计群体如何影响产品设计和上市优先顺序。控制演算法如今涵盖模型预测控制和比例积分微分方法，每种方法都需要量身定制的检验策略。显示设备种类繁多，从传统的手持设备到可穿戴显示器，影响人为因素测试和连接性要求。胰岛素泵包括贴片帮浦、导管泵和无导管泵，每种泵都涉及不同的服务和保固考虑因素。

拥有有效策略的公司优先考虑对 1 型和 2 型糖尿病患者进行更严格的血糖控制和自动化胰岛素输送。设备类型的细分——封闭式、混合封闭式和开环——反映了不同的自动化和监管水平，影响临床试验设计和监测强度。直销、经销商和线上零售商的销售管道策略影响利润结构和通路衝突管理，而诊断中心、居家照护机构、医院和医学研究实验室的最终用户细分则影响培训、服务交付和保固服务。使用者人口统计分为成人和小儿科，成人细分进一步细分为中年、老年和青年人，小儿科细分为青少年和儿童。

这些子群体决定了人体工学、剂量演算法和依从性支持机制。总体而言，此细分框架支援产品优先顺序、有针对性的临床证据生成以及差异化行销方法，使价值提案与不同相关人员群体的需求保持一致。

区域重要性影响美洲、欧洲、中东和非洲以及亚太市场的监管事务、报销模式和供应链策略

区域驱动因素对美洲、欧洲、中东和非洲以及亚太市场的监管时间表、报销途径、临床实践模式和供应链设计的影响各不相同。在美洲，清晰的监管和成熟的报销框架促进了专科中心的快速采用，而私人付款人模式和整合的医疗体系则为基于订阅的服务提供和捆绑式医疗安排创造了机会。美洲的临床实践强调基于结果的报销和大型註册系统，并进行上市后监测和迭代演算法改进。

中东和非洲的法规环境差异庞大，核准集中，各国报销政策有差异。製造商必须应对复杂的医疗技术评估 (HTA) 流程和多样化的临床指南，从而製定量身定制的打入市场策略并产生本地化的证据。同时，亚太地区的特点是都市区快速采用技术，而其他市场则以成本驱动为导向。供应链考量在亚太地区尤其重要，因为製造群在提供规模经济效益的同时，也使企业面临区域贸易政策变化和零件采购风险。

在每个地区，与临床网络、付款人和公共卫生当局的合作对于扩大采用至关重要，而製定特定区域价值提案、证据包和经销伙伴关係的製造商将处于有利地位，可以加速临床整合和商业性吸引力。

竞争定位由整合设备生态系统、软体领先和加速证据生成和市场进入的策略伙伴关係参与企业

人工胰臟设备和系统领域的关键竞争动态反映了现有医疗设备公司、新兴数位健康挑战者以及专业组件供应商之间的拉锯战。市场领导企业透过整合产品系列实现差异化，这些产品组合将高保真感测器与强大的胰岛素帮浦和复杂的控制演算法相结合；而挑战者则通常专注于软体优先的方法，改造现有硬体或提供增强传统设备的演算法迭加。专注于电子机械系统、生物相容性黏合剂和安全通讯模组的组件供应商发挥战略作用，他们使设计更紧凑、更耐用，并符合安全和资料完整性法规。

策略活动以伙伴关係和收购为中心，旨在加快检验系统的上市时间，保护核心演算法方法的智慧财产权，并扩展临床证据库。各公司也正在投资上市后数据平台和付款人合作伙伴关係，以证明其在实际应用中的成本效益。竞争定位越来越依赖不仅提供可靠的设备，还提供培训、远端监控服务和数据分析的生态系统，以帮助客製化个人化治疗。

随着竞争的成熟，透过使用者体验、互通性和售后服务实现差异化将变得与效能指标同样重要，而那些在以患者为中心的设计和可扩展服务交付方面表现出色的公司将更有可能保持竞争优势。

领导者可采取的策略重点是将感测器创新、模组化产品蓝图、弹性供应链和混合定价结合起来，以释放持久的临床和商业性价值

产业领导者应采取一致的策略，在技术创新、切实可行的商业化和供应弹性之间取得平衡。他们应优先投资高精度感测技术和模型预测控制演算法，这些演算法能够证明血糖结果的改善，并简化检验路径。同时，他们在设计产品蓝图时应考虑模组化，使硬体平台能够支援迭代式软体改进和新的演算法功能，而无需完全更换硬体。

从商业性角度来看，我们将推行混合定价模式，将领先与监管机构和付款方合作，共同製定证据生成计划，使临床试验终点与报销标准相一致，并投资于真实世界数据收集，以支持上市后索赔和重复核准。

最后，将以患者为中心的设计融入每个开发阶段，让成人和儿童终端用户参与可用性测试，并为临床医生、居家照护护理人员和诊断中心量身定制培训计划，这将加速产品采用并减少培训阻力。这些倡议使企业能够将技术优势转化为永续的临床和商业性成果。

采用严格的混合方法研究途径，结合专家访谈、设备能力映射、监管分析和情境规划来检验可行的见解

本分析背后的调查方法融合了定性和定量分析，以确保获得可靠且可复製的见解。主要研究包括对不同医疗机构的临床专家、设备工程师、监管专业人员和采购主导者进行结构化访谈，以收集安全性、可用性和采用障碍的经验知识。次要研究整合了同行评审的临床文献、监管指导文件以及已发布的设备互通性和网路安全标准，以彙编技术和政策趋势。

分析方法包括比较设备能力映射，以识别控制演算法、感测器和交付机制之间的能力差距，以及情境分析，以评估供应链对关税变化和采购衝击的反应。证据三角检验透过将关键输入与监管备案文件、临床试验註册和公共公告进行交叉引用，检验了研究结果。在适用的情况下，我们考虑了可用性和人为因素，透过案例研究和最终用户回馈循环，将技术性能与日常患者体验联繫起来。

这种多层次的方法确保策略结论是基于多种证据和平衡的技术特性以及市场进入、法规遵循和临床应用的实际考虑。

策略综合强调需要综合临床证据、以病人为中心的设计和灵活的商业模式，以广泛部署技术潜力

总而言之，人工胰臟系统代表了糖尿病照护领域的关键进步，这得益于感测器可靠性的提升、演算法的复杂度以及穿戴式工程技术的进步。更广泛的临床应用不仅取决于其卓越的血糖控制效果，还取决于将报销、供应链设计和使用者体验与临床实践和患者生活方式的实际情况相结合。贸易动态和政策变化表明，供应链的韧性和灵活的商业模式与技术能力同等重要。

展望未来，整合严谨临床证据生成、以患者为中心的设计和灵活商业结构的相关人员，将有望胜过仅专注于单一技术改进的竞争对手。设备製造商、零件供应商、临床医生、付款人和监管机构之间的协作，对于协调标准、加快核准和确保公平可及性仍然至关重要。最终，成功的设备将结合可证实的临床效益、无缝的使用者体验和永续的经营模式，以支援长期患者参与和医疗系统整合。

这种整合凸显了整个生态系统协调行动的必要性，以将技术前景转化为持续的临床影响和可扩展的商业性成果。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 提高机器学习演算法的整合度，以提供个人化的胰岛素剂量建议
  • 越来越多地采用将 CGM 数据与自动胰岛素输送相结合的混合封闭回路型系统
  • 扩展基于智慧型手机的人工胰腺应用程序，用于即时血糖监测和控制
  • 开发一种能够输送胰岛素和升糖素的双激素系统来改善血糖值稳定性
  • 增加对支援第三方 CGM 和泵浦整合的可互通设备生态系统的投资
  • 生物相容性感测器涂层的进步提高了连续血糖监测仪的寿命和准确性

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

8. 人工胰臟装置系统市场（依组件）

  • 控制演算法
    • 模型预测控制
    • 比例-积分-微分控制
  • 显示装置
    • 传统手持装置
    • 穿戴式显示装置
  • 胰岛素帮浦
    • 贴片帮浦
    • 管泵
    • 无内胎帮浦
  • 感应器
    • 葡萄糖感测器
    • 胰岛素感测器

9. 人工胰臟装置系统市场（按适应症）

  • 1型糖尿病
  • 2型糖尿病

第 10 章。人工胰臟设备系统市场（依设备类型）

  • 封闭回路型系统
  • 混合封闭回路型系统
  • 开放回路系统

第 11 章人工胰臟装置系统市场（依销售管道）

  • 直销
  • 经销商
  • 线上零售商

第 12 章。人工胰臟装置系统市场（按最终用户）

  • 诊断中心
  • 居家照护环境
  • 医院
  • 医学研究所

第 13 章：人工胰臟装置系统市场（按使用者）

  • 成人
    • 中年人
    • 老年人
    • 年轻人
  • 孩子们
    • 青年
    • 孩子

第 14 章。按地区分類的人工胰臟装置系统市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第 15 章人工胰臟装置系统市场（依类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 16 章。人工胰臟装置系统市场（依国家）

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Abbott Laboratories
    • B. Braun Melsungen AG
    • Beta Bionics, Inc.
    • Bigfoot Biomedical Inc.
    • Dexcom, Inc.
    • Diabeloop SA
    • DreaMed Diabetes Ltd.
    • Eli Lilly and Company
    • Glytec, LLC
    • Inreda Diabetic BV
    • Insulet Corporation
    • Johnson & Johnson
    • Medtronic PLC
    • NIKKISO Co., Ltd.
    • Pancreum, Inc.
    • Renfrew Group International
    • Securecell AG
    • Senseonics Holdings, Inc.
    • Sequel Med Tech, LLC
    • Tandem Diabetes Care, Inc.
    • The Menarini Group
Product Code: MRR-4369010658A1

The Artificial Pancreas Device System Market is projected to grow by USD 686.27 million at a CAGR of 8.66% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 353.11 million
Estimated Year [2025] USD 381.64 million
Forecast Year [2032] USD 686.27 million
CAGR (%) 8.66%

A comprehensive orientation that frames the convergence of monitoring, delivery, and algorithms shaping clinical adoption pathways and stakeholder alignment across diabetes care

This executive summary opens with a focused orientation to the artificial pancreas device system ecosystem, outlining the clinical rationale, technological building blocks, and the interplay of regulatory and commercial forces that are driving its evolution. The technology converges continuous glucose monitoring, insulin delivery hardware, and advanced control algorithms to automate glycemic management for people with insulin-requiring diabetes. Clinical outcomes, patient usability, interoperability standards, and long-term adherence remain the primary determinants of clinical utility and commercial uptake.

Moving from concept to mainstream care requires alignment across stakeholders: clinicians who validate safety and efficacy, payers who define reimbursement pathways, regulators who set performance and cybersecurity standards, and manufacturers who optimize cost, manufacturability, and service models. In parallel, real-world evidence and iterative software updates increasingly inform iterative device approvals and post-market surveillance. This convergence shapes both near-term clinical adoption and longer-term shifts in care delivery, where integration with telehealth, remote monitoring, and data-driven patient management becomes central to value creation and system sustainability.

This introduction sets the stage for an in-depth analysis of technological inflection points, policy changes, market access dynamics, and competitive positioning explored in the subsequent sections.

Technological convergence and regulatory adaptation driving sensor precision, predictive control algorithms, and wearable form factor evolution to redefine diabetes management

The landscape for artificial pancreas device systems is undergoing transformative shifts driven by advances in sensing fidelity, algorithmic intelligence, and human factors engineering. Sensor accuracy improvements and longer wear-time profiles have reduced signal noise and calibration burden, which in turn permits control algorithms to operate with higher confidence and more aggressive insulin titration strategies. As a result, algorithm design has shifted from simple proportional approaches to model-based predictive control frameworks that anticipate glycemic excursions and adapt delivery profiles in real time.

Concurrently, device form factors have evolved from bulky handheld controllers to integrated wearables and discreet patch solutions that emphasize patient comfort and adherence. This hardware miniaturization, coupled with improved inter-device communication standards and cloud-enabled analytics, enables seamless remote monitoring and continuous learning systems that refine clinical decision support. Regulatory paradigms are adapting to this software-driven innovation, with pathways that accommodate iterative algorithm updates, real-world evidence requirements, and stricter cybersecurity expectations.

Taken together, these shifts not only improve clinical outcomes but also alter commercial models, incentivizing manufacturers to bundle devices with services, data analytics, and patient engagement platforms that reinforce long-term retention and differentiated value propositions.

Supply chain realignment and commercial model recalibration triggered by new tariff realities, prompting localization, dual sourcing, and service-focused pricing strategies

The imposition of new tariff measures in 2025 has compelled stakeholders to reassess supply chain resilience and cost structures across the artificial pancreas device system value chain. Components such as sensors, microelectronics, and insulin delivery mechanisms are frequently sourced across multiple geographies; therefore, changes in import duties influence decisions on supplier qualification, inventory buffering, and nearshoring alternatives. Manufacturers responded by accelerating localization of critical subassemblies and seeking alternative procurement lanes to mitigate margin compression.

In response to tariff-driven cost pressures, pricing strategies have shifted from flat product pricing toward service-inclusive models that amortize device costs over subscription-based remote monitoring and software maintenance contracts. This approach preserves affordability for end users while maintaining recurring revenue for suppliers. Additionally, manufacturers intensified engagements with local policymakers and trade associations to clarify tariff classifications and to pursue exemptions for medical devices and components essential to public health.

Operationally, firms prioritized dual-sourcing strategies and strategic inventory positioning to minimize disruption to clinical supply. Clinical trial sponsors and hospital procurement teams also adjusted ordering cadences to account for extended lead times, while reimbursement analysts revisited cost-effectiveness assessments to incorporate adjusted procurement costs. As a result, tariff dynamics catalyzed a broader reassessment of how to achieve supply security, regulatory compliance, and sustainable pricing in a more protectionist trade environment.

A multidimensional segmentation-driven perspective that links component technologies, clinical indications, device architectures, sales channels, care settings, and age cohorts to strategic priorities

Insights derived from segment-level analysis reveal how component choices, clinical indication, device architecture, sales channels, end user settings, and demographic cohorts collectively shape product design and go-to-market priorities. Component-level distinctions between control algorithms, display devices, insulin pumps, and sensors drive distinct engineering and regulatory pathways: control algorithms now span model predictive control and proportional integral derivative approaches, each demanding tailored validation strategies; display devices range from traditional handheld units to wearable displays, influencing human factors testing and connectivity requirements; insulin pumps encompass patch pumps, tubed pumps, and tubeless pumps, creating different servicing and warranty considerations; and sensors include glucose sensors and emerging insulin sensors, each with unique calibration and lifespan characteristics.

Indication-specific dynamics differentiate pathways for Type 1 and Type 2 diabetes populations, with Type 1 patients often prioritizing tighter glycemic control and automated insulination, while Type 2 cohorts may demand simpler hybrid solutions integrated with lifestyle management support. Device type segmentation-closed loop systems, hybrid closed loop systems, and open loop systems-reflects varying levels of automation and regulatory scrutiny, affecting clinical trial design and monitoring intensity. Sales channel strategies across direct sales, distributors, and online retailers influence margin structures and channel conflict management, while end user segmentation spanning diagnostic centers, homecare settings, hospitals, and medical research institutes informs training, service delivery, and warranty provisioning. User demographics distinguish adults and pediatrics, with adults further segmented into middle-aged, older, and young adults, and pediatrics split into adolescents and children; these subgroups dictate ergonomics, dosing algorithms, and adherence support mechanisms.

Collectively, this segmentation framework supports product prioritization, targeted clinical evidence generation, and differentiated marketing approaches that align value propositions with the needs of distinct stakeholder groups.

Distinct regional imperatives shaping regulatory pathways, reimbursement models, and supply chain strategies across the Americas, Europe Middle East & Africa, and Asia-Pacific markets

Regional dynamics exert distinct influences on regulatory timelines, reimbursement pathways, clinical practice patterns, and supply chain design across the Americas, Europe Middle East & Africa, and Asia-Pacific. In the Americas, regulatory clarity and established reimbursement frameworks facilitate rapid adoption in specialized centers, while private payer models and integrated health systems create opportunities for subscription-based service offerings and bundled care arrangements. Clinical practice in the Americas emphasizes outcome-driven reimbursement and large-scale registries that support post-market surveillance and iterative algorithm refinement.

Europe Middle East & Africa presents heterogeneous regulatory environments where centralized approvals coexist with country-level reimbursement variability. Manufacturers navigate complex HTA processes and varying clinical guideline adoption, which necessitates tailored market entry strategies and localized evidence generation. Meanwhile, the Asia-Pacific region demonstrates a dynamic mix of rapid technology adoption in urban centers and cost-sensitive procurement in other markets. Supply chain considerations are particularly salient in Asia-Pacific, where manufacturing clusters offer scale advantages but also expose firms to regional trade policy shifts and component sourcing risks.

Across all regions, collaborations with clinical networks, payers, and public health authorities prove pivotal for scaling adoption, and manufacturers that craft region-specific value propositions, evidence packages, and distribution partnerships are better positioned to accelerate clinical integration and commercial traction.

Competitive positioning shaped by integrated device ecosystems, software-first entrants, and strategic partnerships that accelerate evidence generation and market access

Key competitive dynamics in the artificial pancreas device system arena reflect a tug-of-war between established medical device companies, emergent digital health challengers, and specialized component suppliers. Market leaders differentiate through integrated product portfolios that marry high-fidelity sensors with robust insulin pumps and sophisticated control algorithms, while challenger firms often focus on software-first approaches that retrofit existing hardware or offer algorithmic overlays to enhance legacy devices. Component suppliers specializing in microelectromechanical systems, biocompatible adhesives, and secure communication modules play a strategic role by enabling design miniaturization, extended wear times, and regulatory compliance for safety and data integrity.

Strategic activity centers on partnerships and acquisitions that accelerate time-to-market for validated systems, secure intellectual property in core algorithmic approaches, and broaden clinical evidence libraries. Companies are also investing in post-market data platforms and partnerships with payers to demonstrate cost-effectiveness in real-world settings. Competitive positioning increasingly hinges on the ability to deliver not only a reliable device but an ecosystem that includes training, remote monitoring services, and data analytics that inform personalized therapy adjustments.

As competition matures, differentiation by user experience, interoperability, and after-sales service becomes as consequential as performance metrics, and firms that excel in patient-centric design and scalable service delivery will likely sustain a competitive advantage.

Actionable strategic priorities for leaders to combine sensor innovation, modular product roadmaps, resilient supply chains, and hybrid pricing to unlock durable clinical and commercial value

Industry leaders should adopt a cohesive strategy that balances technological innovation with pragmatic commercialization and supply resilience. Prioritize investment in high-accuracy sensing technologies and model predictive control algorithms that demonstrably improve glycemic outcomes while streamlining validation pathways. Concurrently, design product roadmaps that account for modularity so that hardware platforms can support iterative software improvements and new algorithmic capabilities without requiring full hardware replacements.

From a commercial perspective, pursue hybrid pricing models that blend up-front device pricing with subscription services for remote monitoring, clinical support, and software maintenance to preserve margins while improving patient affordability. Strengthen supplier diversification and nearshoring where feasible to reduce exposure to tariff-induced volatility, and develop contingency inventory strategies that limit clinical disruption. Engage early with regulators and payers to co-design evidence generation plans that align clinical trial endpoints with reimbursement criteria, and invest in real-world data collection to support post-market claims and iterative approvals.

Finally, embed patient-centered design into every stage of development by involving adult and pediatric end users in usability testing, and create educational programs tailored to clinicians, homecare providers, and diagnostic centers to accelerate adoption and reduce training friction. These actions will help organizations convert technical gains into sustainable clinical and commercial outcomes.

A rigorous mixed-methods research approach combining expert interviews, device feature mapping, regulatory analysis, and scenario planning to validate actionable insights

The research methodology underpinning this analysis integrates qualitative and quantitative approaches to ensure robust, reproducible insights. Primary research involved structured interviews with clinical experts, device engineers, regulatory specialists, and procurement leads across diverse care settings to capture experiential knowledge about safety, usability, and adoption barriers. Secondary research synthesized peer-reviewed clinical literature, regulatory guidance documents, and published standards for device interoperability and cybersecurity to contextualize technological and policy trends.

Analytical methods included comparative device feature mapping to identify capability differentials among control algorithms, sensors, and delivery mechanisms, as well as scenario analysis to evaluate supply chain responses to tariff changes and procurement shocks. Evidence triangulation validated findings by cross-referencing primary input with regulatory filings, clinical trial registries, and public policy announcements. Where applicable, usability and human factors considerations were assessed through case studies and end-user feedback loops to connect technical performance with day-to-day patient experience.

This layered methodology ensures that strategic conclusions rest on multiple lines of evidence, balancing technical specificity with pragmatic considerations for market access, regulatory compliance, and clinical adoption.

A strategic synthesis emphasizing the need for integrated clinical evidence, patient-focused design, and resilient commercial models to convert technological promise into widespread adoption

In conclusion, artificial pancreas device systems represent a pivotal advance in diabetes care, enabled by improvements in sensor reliability, algorithm sophistication, and wearable engineering. The pathway to wider clinical adoption depends not only on demonstrating superior glycemic control but also on aligning reimbursement, supply chain design, and user experience with the practical realities of clinical practice and patient lifestyles. Trade dynamics and policy shifts have shown how supply chain resilience and adaptable commercial models are as critical as technological competency.

Moving forward, stakeholders that integrate rigorous clinical evidence generation, patient-centered design, and flexible commercial constructs will outpace competitors that focus solely on isolated technological improvements. Collaboration among device manufacturers, component suppliers, clinicians, payers, and regulators remains essential to harmonize standards, accelerate approvals, and ensure equitable access. Ultimately, the devices that succeed will be those that combine demonstrable clinical benefit with seamless user experiences and sustainable business models that support long-term patient engagement and health system integration.

This synthesis underscores the imperative for coordinated action across the ecosystem to translate technological promise into durable clinical impact and scalable commercial outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising integration of machine learning algorithms for personalized insulin dosing recommendations
  • 5.2. Increased adoption of hybrid closed loop systems combining CGM data with automated insulin delivery
  • 5.3. Expansion of smartphone-based artificial pancreas apps for real-time glucose monitoring and control
  • 5.4. Development of dual-hormone systems administering insulin and glucagon for improved glycemic stability
  • 5.5. Growing investment in interoperable device ecosystems supporting third-party CGM and pump integration
  • 5.6. Advances in biocompatible sensor coatings to extend continuous glucose monitor lifespan and accuracy

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Artificial Pancreas Device System Market, by Component

  • 8.1. Control Algorithms
    • 8.1.1. Model Predictive Control
    • 8.1.2. Proportional Integral Derivative Control
  • 8.2. Display Devices
    • 8.2.1. Traditional Handheld Devices
    • 8.2.2. Wearable Display Devices
  • 8.3. Insulin Pumps
    • 8.3.1. Patch Pumps
    • 8.3.2. Tubed Pumps
    • 8.3.3. Tubeless Pumps
  • 8.4. Sensors
    • 8.4.1. Glucose Sensors
    • 8.4.2. Insulin Sensors

9. Artificial Pancreas Device System Market, by Indication

  • 9.1. Type 1 Diabetes
  • 9.2. Type 2 Diabetes

10. Artificial Pancreas Device System Market, by Device Type

  • 10.1. Closed Loop Systems
  • 10.2. Hybrid Closed Loop Systems
  • 10.3. Open Loop Systems

11. Artificial Pancreas Device System Market, by Sales Channel

  • 11.1. Direct Sales
  • 11.2. Distributors
  • 11.3. Online Retailers

12. Artificial Pancreas Device System Market, by End User

  • 12.1. Diagnostic Centers
  • 12.2. Homecare Settings
  • 12.3. Hospitals
  • 12.4. Medical Research Institutes

13. Artificial Pancreas Device System Market, by User

  • 13.1. Adults
    • 13.1.1. Middle-Aged Adults
    • 13.1.2. Older Adults
    • 13.1.3. Young Adults
  • 13.2. Pediatrics
    • 13.2.1. Adolescents
    • 13.2.2. Children

14. Artificial Pancreas Device System Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Artificial Pancreas Device System Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Artificial Pancreas Device System Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Abbott Laboratories
    • 17.3.2. B. Braun Melsungen AG
    • 17.3.3. Beta Bionics, Inc.
    • 17.3.4. Bigfoot Biomedical Inc.
    • 17.3.5. Dexcom, Inc.
    • 17.3.6. Diabeloop SA
    • 17.3.7. DreaMed Diabetes Ltd.
    • 17.3.8. Eli Lilly and Company
    • 17.3.9. Glytec, LLC
    • 17.3.10. Inreda Diabetic B.V.
    • 17.3.11. Insulet Corporation
    • 17.3.12. Johnson & Johnson
    • 17.3.13. Medtronic PLC
    • 17.3.14. NIKKISO Co., Ltd.
    • 17.3.15. Pancreum, Inc.
    • 17.3.16. Renfrew Group International
    • 17.3.17. Securecell AG
    • 17.3.18. Senseonics Holdings, Inc.
    • 17.3.19. Sequel Med Tech, LLC
    • 17.3.20. Tandem Diabetes Care, Inc.
    • 17.3.21. The Menarini Group

LIST OF FIGURES

  • FIGURE 1. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COMPONENT, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INDICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SALES CHANNEL, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SALES CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY USER, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY MODEL PREDICTIVE CONTROL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY MODEL PREDICTIVE CONTROL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY MODEL PREDICTIVE CONTROL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY MODEL PREDICTIVE CONTROL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY MODEL PREDICTIVE CONTROL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY MODEL PREDICTIVE CONTROL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PROPORTIONAL INTEGRAL DERIVATIVE CONTROL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PROPORTIONAL INTEGRAL DERIVATIVE CONTROL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PROPORTIONAL INTEGRAL DERIVATIVE CONTROL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PROPORTIONAL INTEGRAL DERIVATIVE CONTROL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PROPORTIONAL INTEGRAL DERIVATIVE CONTROL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PROPORTIONAL INTEGRAL DERIVATIVE CONTROL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TRADITIONAL HANDHELD DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TRADITIONAL HANDHELD DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TRADITIONAL HANDHELD DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TRADITIONAL HANDHELD DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TRADITIONAL HANDHELD DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TRADITIONAL HANDHELD DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY WEARABLE DISPLAY DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY WEARABLE DISPLAY DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY WEARABLE DISPLAY DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY WEARABLE DISPLAY DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY WEARABLE DISPLAY DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY WEARABLE DISPLAY DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN PUMPS, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN PUMPS, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN PUMPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN PUMPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN PUMPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN PUMPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PATCH PUMPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PATCH PUMPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PATCH PUMPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PATCH PUMPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PATCH PUMPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PATCH PUMPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TUBED PUMPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TUBED PUMPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TUBED PUMPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TUBED PUMPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TUBED PUMPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TUBED PUMPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TUBELESS PUMPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TUBELESS PUMPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TUBELESS PUMPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TUBELESS PUMPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TUBELESS PUMPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TUBELESS PUMPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SENSORS, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SENSORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SENSORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SENSORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SENSORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SENSORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SENSORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY GLUCOSE SENSORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY GLUCOSE SENSORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY GLUCOSE SENSORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY GLUCOSE SENSORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY GLUCOSE SENSORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY GLUCOSE SENSORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN SENSORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN SENSORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN SENSORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN SENSORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN SENSORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN SENSORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TYPE 1 DIABETES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TYPE 1 DIABETES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TYPE 1 DIABETES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TYPE 1 DIABETES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TYPE 2 DIABETES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TYPE 2 DIABETES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TYPE 2 DIABETES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TYPE 2 DIABETES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CLOSED LOOP SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CLOSED LOOP SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CLOSED LOOP SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CLOSED LOOP SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CLOSED LOOP SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CLOSED LOOP SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY HYBRID CLOSED LOOP SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY HYBRID CLOSED LOOP SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY HYBRID CLOSED LOOP SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY HYBRID CLOSED LOOP SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY HYBRID CLOSED LOOP SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY HYBRID CLOSED LOOP SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY OPEN LOOP SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY OPEN LOOP SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY OPEN LOOP SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY OPEN LOOP SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY OPEN LOOP SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY OPEN LOOP SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ONLINE RETAILERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ONLINE RETAILERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ONLINE RETAILERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ONLINE RETAILERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ONLINE RETAILERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ONLINE RETAILERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY HOMECARE SETTINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY HOMECARE SETTINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY HOMECARE SETTINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY HOMECARE SETTINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY MEDICAL RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY MEDICAL RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY MEDICAL RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY MEDICAL RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY MEDICAL RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY MEDICAL RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY USER, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY USER, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADULTS, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADULTS, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADULTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADULTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADULTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADULTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADULTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADULTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY MIDDLE-AGED ADULTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY MIDDLE-AGED ADULTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY MIDDLE-AGED ADULTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY MIDDLE-AGED ADULTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY MIDDLE-AGED ADULTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY MIDDLE-AGED ADULTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY OLDER ADULTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY OLDER ADULTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY OLDER ADULTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY OLDER ADULTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY OLDER ADULTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY OLDER ADULTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY YOUNG ADULTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY YOUNG ADULTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY YOUNG ADULTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY YOUNG ADULTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY YOUNG ADULTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY YOUNG ADULTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PEDIATRICS, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PEDIATRICS, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PEDIATRICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PEDIATRICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PEDIATRICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PEDIATRICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PEDIATRICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADOLESCENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADOLESCENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADOLESCENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADOLESCENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADOLESCENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADOLESCENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CHILDREN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CHILDREN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CHILDREN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CHILDREN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CHILDREN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CHILDREN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 224. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 225. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 226. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 227. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, 2018-2024 (USD MILLION)
  • TABLE 228. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, 2025-2032 (USD MILLION)
  • TABLE 229. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 230. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 231. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN PUMPS, 2018-2024 (USD MILLION)
  • TABLE 232. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN PUMPS, 2025-2032 (USD MILLION)
  • TABLE 233. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
  • TABLE 234. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SENSORS, 2025-2032 (USD MILLION)
  • TABLE 235. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 236. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 237. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 239. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 240. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 241. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 242. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 243. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY USER, 2018-2024 (USD MILLION)
  • TABLE 244. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY USER, 2025-2032 (USD MILLION)
  • TABLE 245. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADULTS, 2018-2024 (USD MILLION)
  • TABLE 246. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADULTS, 2025-2032 (USD MILLION)
  • TABLE 247. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PEDIATRICS, 2018-2024 (USD MILLION)
  • TABLE 248. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PEDIATRICS, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 252. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, 2018-2024 (USD MILLION)
  • TABLE 254. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, 2025-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 256. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 257. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN PUMPS, 2018-2024 (USD MILLION)
  • TABLE 258. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN PUMPS, 2025-2032 (USD MILLION)
  • TABLE 259. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
  • TABLE 260. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SENSORS, 2025-2032 (USD MILLION)
  • TABLE 261. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 262. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 263. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 265. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 266. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 267. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 268. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 269. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY USER, 2018-2024 (USD MILLION)
  • TABLE 270. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY USER, 2025-2032 (USD MILLION)
  • TABLE 271. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADULTS, 2018-2024 (USD MILLION)
  • TABLE 272. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADULTS, 2025-2032 (USD MILLION)
  • TABLE 273. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PEDIATRICS, 2018-2024 (USD MILLION)
  • TABLE 274. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PEDIATRICS, 2025-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. LATIN AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 278. LATIN AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, 2018-2024 (USD MILLION)
  • TABLE 280. LATIN AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, 2025-2032 (USD MILLION)
  • TABLE 281. LATIN AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 282. LATIN AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 283. LATIN AMERICA ARTIFICIAL PANCREAS DEVICE